ESMO Deep Dive: First-Line Therapy for HRD-Negative Advanced Ovarian Cancer 2026
The ESMO Deep Dive: First-Line Therapy for HRD-Negative Advanced Ovarian Cancer 2026 webinar, organized by the European Society for Medical Oncology (ESMO), will take place live on 2 September 2026 […]